- Advertise
- About OncLive
- Editorial Board
- CureToday.com
- TargetedOnc.com
- CancerNetwork.com
- Contact Us
- Privacy
- Terms & Conditions
- Do Not Sell My Information
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
© 2021 MJH Life Sciences™ and OncLive. All rights reserved.
Cedars-Sinai Cancer | Strategic Alliance Partners
Cedars-Sinai Cancer in Los Angeles serves one of the most diverse regions globally. Ranked No. 7 for cancer by U.S. News & World Report 2020-2021, the center’s clinicians are committed to providing compassionate, state-of-the-art care, while its scientists are carrying out the latest translational research and groundbreaking advances. The cancer enterprise includes the Samuel Oschin Comprehensive Cancer Institute, The Angeles Clinic and Research Institute, Tower Hematology Oncology Medical Group, Torrance Memorial Hunt Cancer Center and Cedars-Sinai Tarzana.
Latest from Cedars-Sinai Cancer
Cedars-Sinai Researchers Develop New Melanoma Staging System
September 23, 2021
Article
Cedars-Sinai Cancer researchers have created a new system for classifying melanoma when the disease has spread to the lymph nodes.
Dr. Mita on Treatment Selection in ER+, HER2- Breast Cancer
August 13, 2021
Video
Monica M. Mita, MD, discusses treatment selection for patients with estrogen receptor–positive, HER2-negative breast cancer.
Dr. Basho on the Emergence of Bispecific Antibodies in HER2+ Breast Cancer
August 13, 2021
Video
Reva K. Basho, MD, discusses the emergence of bispecific antibodies in HER2-positive breast cancer.
Dr. Reckamp on the Significance of ALTA in ALK+ NSCLC
August 01, 2021
Video
Karen L. Reckamp, MD, discusses the significance of the final results of the ALTA trial in patients with ALK-positive non–small cell lung cancer.
Predicting the Future of Overcoming EGFR Resistance Mechanisms in NSCLC
July 31, 2021
Article
Sukhmani K. Padda, MD, discusses strategies to overcome EGFR resistance in patients with non–small cell lung cancer.
Dr. Basho on the Evolution of Therapeutic Sequencing in HER2+ Breast Cancer
July 28, 2021
Video
Reva K. Basho, MD, discusses the evolution of therapeutic sequencing in HER2-positive breast cancer.
Dr. Basho on the Integration of Trastuzumab Deruxtecan in HER2+ Breast Cancer
July 22, 2021
Video
Reva K. Basho, MD, discusses the integration of fam-trastuzumab deruxtecan-nxki in HER2-positive breast cancer.
Survival Advantages in Metastatic Breast Cancer Move the Needle Toward Curative-Intent Strategies
July 08, 2021
Article
Heather L. McArthur, MD, MPH, discusses key advances in breast cancer regarding CDK4/6 inhibitors, PI3K inhibitors, and subcutaneous formulations of standard treatments.
Dr. Atkins on Safety Considerations For Neoadjuvant Approaches in Gastric Cancer
June 14, 2021
Video
Katelyn M. Atkins, MD, PhD, discusses safety considerations for neoadjuvant approaches in patients with gastric cancer.
Role of Adjuvant Chemoradiation Under Study in Gastric Cancer
May 16, 2021
Article
Katelyn M. Atkins, MD, PhD, examines the evolving role of radiotherapy in the treatment of patients with gastric cancer, the subgroups who might derive the most benefit from this approach, and ongoing research efforts that are seeking to address remaining questions with this modality.
Gong Gives Perspective on Sequencing Challenges Faced in Advanced HCC
May 14, 2021
Article
Jun Gong, MD, discusses the impact of the IMbrave150 trial on the advanced HCC treatment paradigm and challenges faced with sequencing.
The Future of Cancer Immunotherapy Lies in Combinational Approaches
May 06, 2021
Article
Arsen Osipov, MD, discusses the potential for ongoing research with immunotherapeutic approaches in gastrointestinal malignancies, including CAR T-cell therapy, bispecific T-cell engagers, and vaccines.
Dr. Osipov on the Role of Combination Immunotherapy Across Multiple Tumor Types
April 30, 2021
Video
Arsen Osipov, MD, discusses the role of combination immunotherapy across multiple tumor types.
Dr. Atkins on the Role of Adjuvant Chemoradiation in Gastric Cancer
April 14, 2021
Video
Katelyn M. Atkins, MD, PhD, discusses the role of adjuvant chemoradiation therapy in gastric cancer.
Dr. Lopategui on the Evolution of Targeted Therapies in NSCLC
June 05, 2020
Video
Jean Lopategui, MD, discusses the evolution of targeted therapies in non–small cell lung cancer.
Dr. Natale on the Evolution of Immunotherapy in NSCLC
May 15, 2020
Video
Ronald B. Natale, MD, discusses the evolution of immunotherapy in advanced non–small cell lung cancer.
Dr. Natale on the Evolution of Immunotherapy in NSCLC
May 14, 2020
Video
Ronald B. Natale, MD, discusses the evolution of immunotherapy in advanced non–small cell lung cancer.
Dr. Freedland on Real-World Utility of Enzalutamide in Prostate Cancer
May 12, 2020
Video
Stephen J. Freedland, MD, discusses remaining questions with the real-world utility of enzalutamide in prostate cancer.